Scholarly Index
Bhavana Pothuri
NYU Langone Health; 8,937 total citations; 395 total publications; best world rank #56
NYU Langone Health
8,937Total citations
395Total publications
43H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Ovarian cancer diagnosis and treatment | Lifetime | 524 | US 249 | 97.88 |
| PARP inhibition in cancer therapy | Lifetime | 294 | US 148 | 96.29 |
| COVID-19 and healthcare impacts | Lifetime | 737 | US 259 | 93.05 |
| Endometrial and Cervical Cancer Treatments | Lifetime | 636 | US 271 | 97.15 |
| Intraperitoneal and Appendiceal Malignancies | Lifetime | 494 | US 193 | 94.54 |
| Ovarian cancer diagnosis and treatment | 2021-2025 | 56 | US 15 | 99.00 |
| Endometrial and Cervical Cancer Treatments | 2021-2025 | 109 | US 24 | 98.07 |
| PARP inhibition in cancer therapy | 2021-2025 | 92 | US 38 | 96.64 |
| BRCA gene mutations in cancer | 2021-2025 | 151 | US 72 | 94.59 |
| Genetic factors in colorectal cancer | 2021-2025 | 233 | US 93 | 95.05 |
| Economic and Financial Impacts of Cancer | 2021-2025 | 685 | US 407 | 84.71 |
| Ethics in Clinical Research | 2021-2025 | 395 | US 169 | 83.77 |
| Biomedical Ethics and Regulation | 2021-2025 | 563 | US 227 | 65.99 |